@article{Glannon2008,
abstract = {Many drugs have therapeutic off-label uses for which they were not originally designed. Some drugs designed to treat neuropsychiatric and other disorders may enhance certain normal cognitive and affective functions. Because the long-term effects of cognitive and affective enhancement are not known and may be harmful, a precautionary principle limiting its use seems warranted. As an expression of autonomy, though, competent individuals should be permitted to take cognition- and mood-enhancing agents. But they need to be aware of the risks in chronic use of these agents and to take responsibility for their effects. A reasonable middle ground between these positions is to warn those who choose to enhance that doing so entails risks.},
author = {Glannon, Walter},
doi = {10.1007/s12152-008-9005-9},
file = {:Users/michaelk/Library/Application Support/Mendeley Desktop/Downloaded/Glannon - 2008 - Psychopharmacological enhancement.pdf:pdf},
isbn = {1874-5490},
issn = {1874-5490},
journal = {Neuroethics},
number = {1},
pages = {45--54},
title = {{Psychopharmacological enhancement}},
url = {http://link.springer.com/10.1007/s12152-008-9005-9},
volume = {1},
year = {2008}
}

{"_id":"bN7ndNovGenGsERp5","bibbaseid":"glannon-psychopharmacologicalenhancement-2008","downloads":0,"creationDate":"2019-04-01T06:57:21.601Z","title":"Psychopharmacological enhancement","author_short":["Glannon, W."],"year":2008,"bibtype":"article","biburl":"http://phil-mem.org/phil-mem.bib/","bibdata":{"bibtype":"article","type":"article","abstract":"Many drugs have therapeutic off-label uses for which they were not originally designed. Some drugs designed to treat neuropsychiatric and other disorders may enhance certain normal cognitive and affective functions. Because the long-term effects of cognitive and affective enhancement are not known and may be harmful, a precautionary principle limiting its use seems warranted. As an expression of autonomy, though, competent individuals should be permitted to take cognition- and mood-enhancing agents. But they need to be aware of the risks in chronic use of these agents and to take responsibility for their effects. A reasonable middle ground between these positions is to warn those who choose to enhance that doing so entails risks.","author":[{"propositions":[],"lastnames":["Glannon"],"firstnames":["Walter"],"suffixes":[]}],"doi":"10.1007/s12152-008-9005-9","file":":Users/michaelk/Library/Application Support/Mendeley Desktop/Downloaded/Glannon - 2008 - Psychopharmacological enhancement.pdf:pdf","isbn":"1874-5490","issn":"1874-5490","journal":"Neuroethics","number":"1","pages":"45–54","title":"Psychopharmacological enhancement","url":"http://link.springer.com/10.1007/s12152-008-9005-9","volume":"1","year":"2008","bibtex":"@article{Glannon2008,\nabstract = {Many drugs have therapeutic off-label uses for which they were not originally designed. Some drugs designed to treat neuropsychiatric and other disorders may enhance certain normal cognitive and affective functions. Because the long-term effects of cognitive and affective enhancement are not known and may be harmful, a precautionary principle limiting its use seems warranted. As an expression of autonomy, though, competent individuals should be permitted to take cognition- and mood-enhancing agents. But they need to be aware of the risks in chronic use of these agents and to take responsibility for their effects. A reasonable middle ground between these positions is to warn those who choose to enhance that doing so entails risks.},\nauthor = {Glannon, Walter},\ndoi = {10.1007/s12152-008-9005-9},\nfile = {:Users/michaelk/Library/Application Support/Mendeley Desktop/Downloaded/Glannon - 2008 - Psychopharmacological enhancement.pdf:pdf},\nisbn = {1874-5490},\nissn = {1874-5490},\njournal = {Neuroethics},\nnumber = {1},\npages = {45--54},\ntitle = {{Psychopharmacological enhancement}},\nurl = {http://link.springer.com/10.1007/s12152-008-9005-9},\nvolume = {1},\nyear = {2008}\n}\n","author_short":["Glannon, W."],"key":"Glannon2008","id":"Glannon2008","bibbaseid":"glannon-psychopharmacologicalenhancement-2008","role":"author","urls":{"Paper":"http://link.springer.com/10.1007/s12152-008-9005-9"},"downloads":0},"search_terms":["psychopharmacological","enhancement","glannon"],"keywords":[],"authorIDs":[],"dataSources":["xpm4HPGis5kQeHY7z"]}